Clayface Starts at 75% on Rotten Tomatoes as Critics Split on DC's Body-Horror Bet

First reviews for DC Studios' Clayface landed on 21 October 2026, two days before the film opens in the United States and the United Kingdom on 23 October, with Australia opening a day earlier on 22 October. Rotten Tomatoes recorded 75% from the first batch, and no audience score existed yet. The batch contains both enthusiastic notices and blunt dismissals, which makes the number less interesting than the argument behind it.

Related reading: Wicker Wins Over Critics and Audiences. Its $5.75 Million Opening Is the Interesting Part. · Wildwood Opens at 100% on Rotten Tomatoes as Metacritic Stands at 87.

The film is a smaller bet than the usual DC release. James Watkins directed from a screenplay by Mike Flanagan and Hossein Amini. Matt Reeves, Lynn Harris, James Gunn and Peter Safran are among the producers, Warner Bros. Pictures distributes, and DC Studios made it with 6th & Idaho. It runs 1 hour 48 minutes and carries an R rating. The Guardian put the budget at around $40 million, a reported figure rather than a studio confirmation.

The premise is a revenge story with a horror engine bolted to it. Matt Hagen, played by Tom Rhys Harries, is a Welsh actor and recent Oscar nominee who returns to Gotham, sleeps with the girlfriend of crime boss Markos Szabos, and has his face slashed for it. He turns to Dr. Caitlyn Corr, played by Naomi Ackie, and her experimental nanotechnology. A megadose lets him reshape his face at will, and the film turns into a body-horror revenge plot. David Dencik plays Szabos, Max Minghella plays John, and Eddie Marsan, Nancy Carroll and Joshua James round out the cast.

What the enthusiastic reviews see

Frank Scheck at The Hollywood Reporter called it “a bona fide body-horror delight” and wrote that “Clayface emerges as one of the year's big surprises.” He singled out the practical effects, an airplane-lavatory scene and a nightclub set piece. Guy Lodge at Variety agreed on the surprise, and went further on craft: “In nearly every department, Clayface exceeds expectations.” Lodge's full line adds that the film manages this “without getting ideas above its spiritual B-movie station,” which is a compliment about discipline as much as quality.

Two more notices point the same way. Amelia Emberwing at Pickety Witch wrote that “the film's complete lack of identity crisis is going to go a very long way with fans,” a useful phrase for a shared-universe film that has to introduce a villain without a hero to bounce off. Matt Donato at Daily Dead called it a “grimy antidote to formulaic comic book adaptations.” The word grimy is doing real work there: this is a film with a slashed face, an experimental drug and a man who can wear someone else's features.

“Clayface emerges as one of the year's big surprises.” — Frank Scheck, The Hollywood Reporter, 21 October 2026

Where the objections land

Benjamin Lee at The Guardian was unmoved. His verdict line reads “flesh-stretching DC body horror is very gory but not very good,” and he called the film “a clumsily missed opportunity.” Two of his complaints are about production scale: he argued that Clayface looks closer to a network TV series than a feature, and that Liverpool stands in for Gotham without convincing anyone.

Kate Erbland at IndieWire wrote that “Watkins' film confounds much more than it compels.” Brian Tallerico at RogerEbert.com said much of the film “lacks the visual language of the best of this universe.” Josh Wilding at ComicBookMovie.com reached for the least flattering comparison available, calling it Morbius “but slightly better,” and added that it is “too tame to be a classic horror movie and too bland to be a great DC Comics adaptation.” Spencer Perry at ComicBook.com put the split in one sentence: “Clayface could have been worse, but what's frustrating is the knowledge that the movie could have been better, too.”

Read together, the negative notices fault the execution rather than the premise. Lee wanted more craft, Wilding wanted more horror, Tallerico wanted the visual grammar the rest of the franchise has. None of them says a low-budget Clayface was a bad idea.

The score is a snapshot, not a verdict

Why a 75% film at this budget matters

The commercial context is harsher than the reviews. DC's previous release, Supergirl, opened in 2026 and bombed. The Guardian reports that experts believe it may have cost Warner Bros upwards of $200 million in losses, a figure the studio has not confirmed. That same piece notes that 10 superhero films were released in 2019 and that the genre has contracted since, which is context rather than a measured trend.

Against that, a $40 million standalone villain origin story is a different kind of wager. It sits closer to the strategy behind 2019's Joker than to a $200 million tentpole, though Joker's gross of more than $1 billion and its Oscars are background here, not a quality comparison. The arithmetic is simple: a film at this price can be profitable at ticket sales that would be a disaster for Supergirl, and a 75% critical score matters less to a $40 million film than it would to a tentpole costing several times as much. The case for the model does not depend on the reviews being wrong.

The case against is also about scale. A small film has less room to fix what reviewers disliked. If Liverpool cannot pass for Gotham, that is a budget decision as much as an artistic one, and the same goes for the look that Tallerico and Lee both flagged. A bigger production could have bought its way out of those complaints. This one could not, and the reviews that mention them are describing the trade-off the budget required.

The R rating narrows the audience at the door. A body-horror film built on a slashed face and a drug that lets a man wear other people's features is not a family release, and the budget reflects that.

A villain film with no hero to lean on

Villain origin stories carry a structural problem that hero films avoid. The audience is asked to follow a man toward the moment he becomes worse, and the payoff is a transformation rather than a victory. Clayface handles part of that with the revenge plot: Hagen has a specific grievance, a specific target and a specific clock, which is a workable engine for a film with no hero to resolve the story.

It is also the third theatrical entry in the DC Universe, after Superman in 2025 and Supergirl in 2026, and the first of the three built around a villain. That makes the film a test of whether a DC release can sell on horror rather than on a costume the audience already knows. The notices that praise it tend to credit its directness. The ones that do not describe the same directness as thinness, and Perry's complaint, that the better film is visible inside the one that got made, is the clearest example.

A Clayface release also cannot lean on a rogues' gallery or a crossover tease the way a Batman film can, so it has to work as a horror film first. Critics reached for David Cronenberg's The Fly, The Substance, Darkman and Thinner rather than for other cape films, which suggests the filmmakers pitched it at that audience. Whether it reads as confidence or as a costume is the disagreement running through the whole batch.

What the reviews agree on

Almost every notice singles out Harries. The disagreement is about the material around him, not the performance, and Ackie gets similar treatment for a role that could easily have been an exposition machine. That matters for how the film lands with people who ignore critics: the parts audiences tend to notice first, the lead and the effects, are the parts the reviews like.

Practical effects are the other repeated note, and they are the part of the production least tied to budget. A film that cannot afford a convincing Gotham can still afford a good prosthetic, a wet set piece and a camera close enough to sell both. Scheck's mention of the airplane lavatory and the nightclub suggests the money went where the horror is, which is the sensible place for a $40 million picture.

Caveats

Three qualifications sit under these numbers. The 75% figure is a snapshot from the first batch of reviews, not a settled score, and it will move. The $40 million budget is The Guardian's reported number, not something Warner Bros. has confirmed. And the film had not opened in the US or UK when this was written, so no audience reaction, CinemaScore or opening-weekend figure exists yet. Every verdict quoted here is one critic's opinion, attributed by name.

What to watch

• The Tomatometer after opening weekend. A first-batch 75% can settle in either direction once the full review set lands.
• Audience scores. No audience rating existed at publication. The gap between critics and ticket buyers will say more about the film's legs than the critic score will.
• Opening weekend against the budget. At a reported $40 million, Clayface does not need to lead the box office to justify itself.
• Whether DC repeats the model. A profitable small film makes the next low-budget villain origin easier to greenlight. A loss makes the case for retreating to tentpoles.

Ticket buyers get their say on 23 October.

Cover image: official Clayface still, courtesy of Warner Bros. Pictures and DC Studios (company-distributed press asset).